210 related articles for article (PubMed ID: 19508393)
1. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.
Morecroft I; Murray A; Nilsen M; Gurney AM; MacLean MR
Br J Pharmacol; 2009 Aug; 157(7):1241-9. PubMed ID: 19508393
[TBL] [Abstract][Full Text] [Related]
2. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
[TBL] [Abstract][Full Text] [Related]
3. Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
Sedivy V; Joshi S; Ghaly Y; Mizera R; Zaloudikova M; Brennan S; Novotna J; Herget J; Gurney AM
Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(1):L48-57. PubMed ID: 25361569
[TBL] [Abstract][Full Text] [Related]
4. Beraprost Upregulates KV Channel Expression and Function via EP4 Receptor in Pulmonary Artery Smooth Muscle Cells Obtained from Rats with Hypoxia-Induced Pulmonary Hypertension.
Tian H; Fan F; Geng J; Deng J; Tian H
J Vasc Res; 2019; 56(4):204-214. PubMed ID: 31189158
[TBL] [Abstract][Full Text] [Related]
5. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
[TBL] [Abstract][Full Text] [Related]
6. Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension.
Mondéjar-Parreño G; Barreira B; Callejo M; Morales-Cano D; Barrese V; Esquivel-Ruiz S; Olivencia MA; Macías M; Moreno L; Greenwood IA; Perez-Vizcaino F; Cogolludo A
Hypertension; 2020 Oct; 76(4):1134-1146. PubMed ID: 32829658
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated K+ channels at an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets.
Fike CD; Kaplowitz MR; Zhang Y; Madden JA
Am J Physiol Lung Cell Mol Physiol; 2006 Dec; 291(6):L1169-76. PubMed ID: 16861383
[TBL] [Abstract][Full Text] [Related]
8. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.
Pozeg ZI; Michelakis ED; McMurtry MS; Thébaud B; Wu XC; Dyck JR; Hashimoto K; Wang S; Moudgil R; Harry G; Sultanian R; Koshal A; Archer SL
Circulation; 2003 Apr; 107(15):2037-44. PubMed ID: 12695303
[TBL] [Abstract][Full Text] [Related]
9. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
10. HIV transgene expression impairs K
Mondejar-Parreño G; Morales-Cano D; Barreira B; Callejo M; Ruiz-Cabello J; Moreno L; Esquivel-Ruiz S; Mathie A; Butrous G; Perez-Vizcaino F; Cogolludo A
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L711-L723. PubMed ID: 30136611
[TBL] [Abstract][Full Text] [Related]
11. The novel K
Villegas-Esguevillas M; Cho S; Vera-Zambrano A; Kwon JW; Barreira B; Telli G; Navarro-Dorado J; Morales-Cano D; de Olaiz B; Moreno L; Greenwood I; Pérez-Vizcaíno F; Kim SJ; Climent B; Cogolludo A
Biomed Pharmacother; 2023 Aug; 164():114952. PubMed ID: 37295249
[TBL] [Abstract][Full Text] [Related]
12. Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension.
Agard C; Rolli-Derkinderen M; Dumas-de-La-Roque E; Rio M; Sagan C; Savineau JP; Loirand G; Pacaud P
Br J Pharmacol; 2009 Nov; 158(5):1285-94. PubMed ID: 19814724
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism.
Absi M; Eid BG; Ashton N; Hart G; Gurney AM
PLoS One; 2019; 14(8):e0220473. PubMed ID: 31369604
[TBL] [Abstract][Full Text] [Related]
14. TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension.
Xia Y; Fu Z; Hu J; Huang C; Paudel O; Cai S; Liedtke W; Sham JS
Am J Physiol Cell Physiol; 2013 Oct; 305(7):C704-15. PubMed ID: 23739180
[TBL] [Abstract][Full Text] [Related]
15. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.
Yeung S; Schwake M; Pucovský V; Greenwood Ia
Br J Pharmacol; 2008 Sep; 155(1):62-72. PubMed ID: 18536747
[TBL] [Abstract][Full Text] [Related]
16. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.
Wandall-Frostholm C; Skaarup LM; Sadda V; Nielsen G; Hedegaard ER; Mogensen S; Köhler R; Simonsen U
PLoS One; 2014; 9(5):e97687. PubMed ID: 24858807
[TBL] [Abstract][Full Text] [Related]
18. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
19. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
